WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007011960) METHODS AND AGENTS TO TREAT AUTOIMMUNE DISEASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/011960    International Application No.:    PCT/US2006/027903
Publication Date: 25.01.2007 International Filing Date: 18.07.2006
IPC:
A01N 63/00 (2006.01), A61K 45/00 (2006.01), A61K 47/00 (2006.01)
Applicants: ADVANCED IMMUNE BIOTECHNOLOGIES, INC. [US/US]; P.O. Box 560, Palisades, NY 10964 (US) (For All Designated States Except US).
AL-HARBI, Saleh, A. [KW/KW]; (KW) (For US Only).
HAINES, David, D. [US/US]; (US) (For US Only)
Inventors: AL-HARBI, Saleh, A.; (KW).
HAINES, David, D.; (US)
Agent: COHEN, Mark, S.; PEARL COHEN ZEDEK LATZER, LLP, 1500 Broadway, 12th Floor, New York, NY 10036 (US)
Priority Data:
60/667,030 18.07.2005 US
Title (EN) METHODS AND AGENTS TO TREAT AUTOIMMUNE DISEASES
(FR) METHODES ET AGENTS PERMETTANT DE TRAITER LES MALADIES AUTO-IMMUNES
Abstract: front page image
(EN)A therapeutic method for preventing, suppressing, or treating an autoimmune disease is described. This method involves administering to a patient suffering from an autoimmune disease an effective amount of a composition containing an allogeneic or autologous leucocyte cell population derived from a healthy donor. The composition is administered by subcutaneous injection and induces an immunological response in recipient patients sufficient to reduce incidence, prevalence, frequency, or severity of the autoimmune disease.
(FR)L'invention concerne une méthode thérapeutique permettant de prévenir, guérir ou traiter une maladie auto-immune. Ladite méthode implique l'administration à un patient souffrant d'une maladie auto-immune d'une quantité efficace d'une composition contenant une population de cellules leucocytaires allogéniques ou autologues dérivées d'un donneur sain. Cette composition est administrée par injection sous-cutanée et induit une réponse immunologique chez les patients receveurs suffisante pour réduire l'incidence, la prévalence, la fréquence ou la sévérité de la maladie auto-immune.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)